We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




High-Energy Ultrasound Provides Clearer View of Liver Tumors

By MedImaging staff writers
Posted on 28 Jan 2008
A high-energy form of ultrasound imaging generates images of liver tumors that are better than those made with traditional ultrasound, according to results from a clinical study. More...


The study, performed by researchers from Duke University's Pratt School of Engineering (Durham, NC, USA), suggests that the imaging method known as acoustic radiation force impulse (ARFI) ultrasound might offer a new tool for screening patients at increased risk for liver cancers, according to the researchers. They reported that it might also play a useful role in guiding biopsy procedures and minimally invasive therapies geared at destroying cancerous tissues found deep in the abdomen.

The researchers reported their findings January 7, 2008, in the journal Physics in Medicine and Biology. The work was funded by the U.S. National Institutes of Health (Bethesda, MD, USA) with system support from Siemens Medical Solutions (Erlangen, Germany).

First developed six years ago by Duke biomedical engineers Drs. Gregg Trahey and Kathy Nightingale, ARFI uses high-energy sound waves to push on tissues like sonic fingers. A tracking beam then captures the movement of the tissue, providing a measure of its elasticity or stiffness.

"To our knowledge, these are the first images of abdominal malignancies in humans that show tissue elasticity,” said Dr. Trahey, professor of biomedical engineering, radiology, and medical physics at Duke. The preliminary findings have already led Siemens to pursue a product prototype that will combine traditional ultrasound with ARFI, he added.

Typically, primary liver cancers are soft while those that have metastasized from other organs are hard. ARFI may be able to tell the difference between hard and soft tumors, according to Dr. Trahey. "If borne out in further studies, [that discriminating ability] suggests that ARFI may be useful in guiding treatment decisions. All current imaging methods--including CT [computed tomography], MRI [magnetic resonance imaging], and ultrasound--have mediocre performance in the detection of early liver cancers,” Dr. Trahey added. "There is a potential role for ARFI because it is low cost and can be built on conventional ultrasound machines.”

Traditional ultrasound is now the guidance method of choice in many hospitals for procedures targeting the liver, kidneys, pancreas, and lymph nodes, according to Dr. Trahey. Ultrasound has advantages in that it is widely available, low cost, and does not expose patients to ionizing radiation. However, a considerable number of tumors are difficult to see with this technique, requiring physicians to resort to alternatives such as CT and MRI, which add to the complexity and cost.

In the new study, the researchers captured ARFI images of 12 tumors in nine patients, including seven liver and two kidney tumors, and compared them to conventional ultrasound. The ARFI images showed greater contrast than standard ultrasound, providing clearer definition of the edges of cancerous masses.


Related Links:
Duke University's Pratt School of Engineering

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.